Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

Department of Biochemistry and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Aging cell (Impact Factor: 6.34). 04/2008; 7(2):137-47. DOI: 10.1111/j.1474-9726.2007.00360.x
Source: PubMed


Beta-site APP-cleaving enzyme 1 (BACE1) expression is elevated in the brains of Alzheimer's disease (AD) patients and in aged-animal models. Because both AD and aging are associated with disrupted calcium homeostasis, we investigated the role of nuclear factor of activated T cells (NFAT) - a transcription factor regulated by the calcium- and calmodulin-dependent phosphatase calcineurin - in BACE1 expression. BACE1 expression was stimulated by a calcium ionophore in primary cortical cultures, and by SH-SY5Y neuroblastoma cells, which was both blocked by pretreatment with either cyclosporin A, an inhibitor of calcineurin, or ethyleneglycotetraacetic acid, a calcium chelator. Gel shift assays revealed direct binding of NFAT1 to specific DNA sequences within the BACE1 gene promoter region. Treatment with amyloid beta (Abeta), one of the major factors in AD pathogenesis, stimulated activation and nuclear translocation of NFAT1 following up-regulation of BACE1 expression. In addition, primary cortical cultures from Tg2576 mouse brains generated more Abeta by ionophore stimulation, which was reversed by cyclosporin A treatment. Furthermore, NFAT1 activation was observed in Tg2576 mouse brains. These results suggest that calcium ionophore- or Abeta-induced increases in intracellular calcium concentration stimulate BACE1 expression, resulting in accelerated Abeta generation, and that this process is mediated through the calcineurin-NFAT1 signaling pathway. This process may play a significant role in the pathogenesis of AD and aging.

Download full-text


Available from: Seok Min Jin, May 21, 2015
  • Source
    • "Notably, increased cytosolic calcium levels and ryanodine receptor-mediated calcium release can further facilitate formation of Aβ peptides through calcium-mediated β-secretase activity among other mechanisms (Chen et al., 2012; Cho et al., 2008; Hayley et al., 2009; Oules et al., 2012; Small et al., 2009). Similar patterns exist for neurofibrillary tangles composed of hyperphosphorylated tau, another diagnostic feature of AD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Calcium ions are versatile and universal biological signaling factors that regulate numerous cellular processes ranging from cell fertilization, to neuronal plasticity that underlies learning and memory, to cell death. For these functions to be properly executed, calcium signaling requires precise regulation, and failure of this regulation may tip the scales from a signal for life to a signal for death. Disruptions in calcium channel function can generate complex multi-system disorders collectively referred to as "calciumopathies" that can target essentially any cell type or organ. In this review, we focus on the multifaceted involvement of calcium signaling in the pathophysiology of Alzheimer's disease, and summarize the various therapeutic options currently available to combat this disease. Detailing the series of disappointing AD clinical trial results on cognitive outcomes, we emphasize the urgency to design alternative therapeutic strategies if synaptic and memory functions are to be preserved. One such approach is to target early calcium channelopathies centrally linked to AD pathogenesis.
    European journal of pharmacology 12/2013; 739. DOI:10.1016/j.ejphar.2013.11.012 · 2.53 Impact Factor
  • Source
    • "Another calcium-dependent transcription factor regulates BACE1 transcription. The calcium-activated nuclear factor of activated T-cells 1 (NFAT1), which is abnormally activated in transgenic mice brain [145], translocates to the nucleus, binds to BACE1 promoter, activates its transcription and increases Aβ generation, as demonstrated in vitro[145]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a complex age-related pathology, the etiology of which has not been firmly delineated. Among various histological stigmata, AD-affected brains display several cellular dysfunctions reflecting enhanced oxidative stress, inflammation process and calcium homeostasis disturbance. Most of these alterations are directly or indirectly linked to amyloid beta-peptides (Abeta), the production, molecular nature and biophysical properties of which likely conditions the degenerative process. It is particularly noticeable that, in a reverse control process, the above-described cellular dysfunctions alter Abeta peptides levels. beta-secretase betaAPP-cleaving enzyme 1 (BACE1) is a key molecular contributor of this cross-talk. This enzyme is responsible for the primary cleavage generating the N-terminus of "full length" Abeta peptides and is also transcriptionally induced by several cellular stresses. This review summarizes data linking brain insults to AD-like pathology and documents the key role of BACE1 at the cross-road of a vicious cycle contributing to Abeta production.
    Molecular Neurodegeneration 10/2012; 7(1):52. DOI:10.1186/1750-1326-7-52 · 6.56 Impact Factor
  • Source
    • "BACE1-mediated β-cleavage has been showed to be physiologically modulated by different spliced transcripts [29] and the activation of protein kinase C [30]. Impaired intracellular calcium homeostasis may stimulate BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling pathway, leading to accelerated production of Aβ [31]. BACE1 could be modulated by Aβ42, but not Aβ40, via an NFκB-dependent signaling pathway [32], and Aβ42-positive plaques could increase BACE1 levels in surrounding neurons before neuron loss occurs [33]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a common neurodegenerative disease characterized clinically by progressive deterioration of memory, and pathologically by histopathological changes including extracellular deposits of amyloid-beta (A-beta) peptides forming senile plaques (SP) and the intracellular neurofibrillary tangles (NFT) of hyperphosphorylated tau in the brain. This review focused on the new developments of amyloid cascade hypothesis with details on the production, metabolism and clearance of A-beta, and the key roles of some important A-beta-related genes in the pathological processes of AD. The most recent research advances in genetics, neuropathology and pathogenesis of the disease were also discussed.
    Translational Neurodegeneration 09/2012; 1(1):18. DOI:10.1186/2047-9158-1-18
Show more